Share this:
Published on July 02, 2020 at 08:40AM
The Securities and Exchange Commission today announced that Boston-based pharmaceutical company Alexion Pharmaceuticals Inc. has agreed to pay more than $21 million to resolve charges that it violated the books and records and internal accounting…
https://ift.tt/3iibVXr
More Stories
SEC: SEC Charges U.S. Promoters of $2 Billion Global Crypto Lending Securities Offering
SEC: SEC Charges Mutual Fund Executives with Misleading Investors Regarding Investment Risks in Funds that Suffered $1 Billion Trading Loss
SEC: SEC Awards More Than $4 Million to Whistleblower